主要文件

查看所有文档

197602

奎宁环

Name: 奎宁环
Brand: ALDRICH

97%

别名:

1-氮杂双环[2.2.2]辛烷, ABCO

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₇H₁₃N

化学文摘社编号:

100-76-5

分子量:

111.18

UNSPSC Code:

12352100

NACRES:

NA.22

PubChem Substance ID:

24851837

EC Number:

202-887-1

Beilstein/REAXYS Number:

103111

MDL number:

MFCD00006690

Assay:

97%

Form:

solid

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

vapor pressure

1.5 mmHg ( 20 °C)

Quality Level

100

assay

97%

form

solid

mp

157-160 °C (lit.)

solubility

H₂O: very slightly soluble, H₂O: very soluble, alcohol: miscible, diethyl ether: miscible, organic solvents: very soluble

SMILES string

C1CN2CCC1CC2

InChI

1S/C7H13N/c1-4-8-5-2-7(1)3-6-8/h7H,1-6H2

InChI key

SBYHFKPVCBCYGV-UHFFFAOYSA-N

Gene Information

rat ... Chrm1(25229)

说明

General description

奎宁环是一种双环三级胺，具有桥头氮原子结构，常用于合成碘鎓复合物，并用作光诱导反应的氢原子转移(HAT)催化剂。

Application

奎宁环可用作以下反应的催化剂：

醛与丙烯酸甲酯的贝里斯-希尔曼反应。
α-甲基葡萄糖转化为α-甲基阿洛糖的差向异构化反应。

它也可作为反应物在乙酸钾存在的情况下与5-溴-2-氰基吡啶反应合成5-[4-[2-(乙酰氧基)乙基]-1-吡啶基]-2- 氰基吡啶。

pictograms

GHS06,GHS05

signalword

Danger

hcodes

H301,H310,H315,H318

pcodes

P262 - P280 - P301 + P310 + P330 - P302 + P352 + P310 - P305 + P351 + P338 + P310

Hazard Classifications

Acute Tox. 2 Dermal - Acute Tox. 3 Oral - Eye Dam. 1 - Skin Irrit. 2

存储类别

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

[PAF-antagonists with phospholipid structure. 3. Phospholipids with heterocyclane head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationship].

H P Kertscher et al.

Die Pharmazie, 46(11), 772-774 (1991-11-01)

A series of 13 PAF-analogues with heterocyclane head groups and variation of the P-N-distance on the C-3-position of the backbone were synthesized. The proaggregatory and inhibitory potencies on rabbit and human blood platelets in vitro was evaluated. Investigations of structure-activity

Journal of the American Chemical Society, 115, 7047-7047 (1993)

[PAF-antagonists with phospholipid structure. 4. Alkylcarbamoylphospholipids with heteroarene and heterocyclase head groups and variation of the P-N-distance; synthesis, characterization and structure-activity relationship].